Matthew Berman

𝐋𝐚𝐭𝐞𝐬𝐭 𝐧𝐞𝐰𝐬 𝐟𝐫𝐨𝐦 𝐍𝐞𝐰 𝐘𝐨𝐫𝐤'𝐬 𝐋𝐞𝐠𝐢𝐬𝐥𝐚𝐭𝐢𝐯𝐞 𝐒𝐞𝐬𝐬𝐢𝐨𝐧 𝐚𝐧𝐝 𝐰𝐡𝐲 𝐢𝐭 𝐦𝐚𝐭𝐭𝐞𝐫𝐬 𝐭𝐨 𝐭𝐡𝐨𝐬𝐞 𝐨𝐟 𝐮𝐬 𝐢𝐧 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲 𝐚𝐧𝐝 𝐏𝐞𝐧𝐧𝐬𝐲𝐥𝐯𝐚𝐧𝐢𝐚. New York's legislative changes may influence regulatory, economic, and policy shifts in New Jersey and Pennsylvania, promoting a more unified and competitive cannabis industry in the region. ❓𝐖𝐡𝐚𝐭 𝐚𝐫𝐞 𝐲𝐨𝐮𝐫 𝐭𝐡𝐨𝐮𝐠𝐡𝐭𝐬 𝐨𝐧 𝐭𝐡𝐢𝐬: 𝐃𝐨 𝐰𝐞 𝐚𝐝𝐯𝐨𝐜𝐚𝐭𝐞 𝐟𝐨𝐫 𝐭𝐡𝐞 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐜𝐚𝐧𝐧𝐚𝐛𝐢𝐬 𝐢𝐧𝐬𝐮𝐫𝐚𝐧𝐜𝐞 𝐛𝐢𝐥𝐥 𝐚𝐧𝐝 𝐭𝐡𝐞 𝐂𝐌𝐄 𝐛𝐢𝐥𝐥 𝐡𝐚𝐫𝐝 𝐢𝐧 𝐭𝐡𝐞 𝐮𝐩𝐜𝐨𝐦𝐢𝐧𝐠 𝐬𝐞𝐬𝐬𝐢𝐨𝐧 𝐭𝐨 𝐞𝐧𝐬𝐮𝐫𝐞 𝐜𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐜𝐨𝐯𝐞𝐫𝐚𝐠𝐞 𝐚𝐧𝐝 𝐬𝐮𝐩𝐩𝐨𝐫𝐭 𝐟𝐨𝐫 𝐦𝐞𝐝𝐢𝐜𝐚𝐥 𝐜𝐚𝐧𝐧𝐚𝐛𝐢𝐬 𝐩𝐚𝐭𝐢𝐞𝐧𝐭𝐬 𝐚𝐧𝐝 𝐩𝐫𝐨𝐟𝐞𝐬𝐬𝐢𝐨𝐧𝐚𝐥𝐬.❓ Here's the recap on NY: On June 8, the NYS Legislative Session ended. Key cannabis-related initiatives included: 🔸 Enhanced enforcement powers 🔸 A new 9% wholesale tax replacing the THC Potency Tax 🔸 A reduction in the Medical Excise Tax from 7% to 3.15%. These changes aim to streamline taxation and strengthen regulatory oversight, fostering a more structured cannabis market. The session also saw the passage of several cannabis bills: Passed Both Houses: 🔸 S.9679-A/A.10398-A: Permits cannabis showcase events, promoting industry growth and consumer education. 🔸 S.1752/A.1234: Includes cannabis in the definition of crops and livestock, recognizing its agricultural value. 🔸 S.9359/A.10196: Allows electronic returns for cannabis product distributors, simplifying administrative processes. Passed Senate Only: 🔸 S.7528/A.7718: Adds a non-voting member from the Division of Service-Disabled Veterans’ Business Development to the state Cannabis Advisory Board, ensuring representation for veterans. 🔸 S.7504/A.7694: Expands membership eligibility for Adult-Use Cooperative licenses, broadening participation in the industry. 🔸 S.8683-A/A.9311-A: Clarifies employment terms for those under state supervision, facilitating workforce reintegration. 🔸 S.2566-B: Addresses medical cannabis use and reciprocity with other states, enhancing patient access. 🔸 A.7826: Similar to S.2566-B but needs amendments due to late changes in the Senate. The Governor has until 12/31/2024 to sign or veto these bills. Any unsigned bills will be reintroduced in the next legislative cycle starting in 2025. This timeline provides a critical window for advocacy and potential amendments to refine the legislation further. #HerbalRubiksCube #Cannabis #CannabisLegislation #MedicalCannabis

2

📅 Mark your calendars for the next NY Cannabis Control Board meeting on June 11th. Which licenses will make the cut this month? Will the discussions be as dynamic as the last session? I'm particularly eager to see if the CCB plans to approve all licenses recommended by the Office. Stay tuned for updates and insights! 🌿 #CannabisIndustry #CCB #CannabisLicensing #RegulatoryUpdates

4

New Jersey is the market to watch! Love this article by Benzinga Cannabis! It's thrilling to see the New Jersey cannabis industry thriving, with a 23% increase in total revenue in the last quarter of 2023, particularly in the pre-roll segment, where sales have risen by 8%. Despite regulatory hurdles and limited brand diversity, the market is seeing robust growth, with leaders like Verano holding a 21% share and Miss Grass capturing 13% with its 0.4g 5-pack minis. This is just the beginning! There are so many more brands coming into the NJ market. Benzinga's Cannabis Capital Conference will be doing a one-day summit in NJ on June 17th and I will be there! Hope to see you! Elliot Lane Patrick Lane Emily Lehmann Jeni Cohen Elana Cohen Cassie Tomaselli Lori Ferrara David Cunic Brian Dowling Philip DeMuro Chris Vaglio ⚡️Gian Lombardi Gabriella Lombardi Wilday Kate Miller Rachel Wright, CPA, MST Michael Schwamm Kevin Cassidy, CPA Greg Hill Steve Goldner LKP Impact Consulting, LLC Avicenna Leadership Group Eduardo Provencio Shaan Kapoor Tripp Murray #NewJerseyCannabis #MarketGrowth #CannabisIndustry https://lnkd.in/geHUeJWD

94

7 Comments

For those who wonder how cannabis is grown and the details, here is an episode of Cannacribs, which walks you through the entire Culta process! Our secret is our team....... https://lnkd.in/e4df2r4Z

23

The Long Island Cannabis Club, a new cannabis dispensary located at 94 East Industry Court in Deer Park, is set to host its grand opening on December 6, 2024. Spanning 4,200 square feet, the dispensary is owned by a diverse group of five entrepreneurs with backgrounds in consulting, alternative medicine, engineering, and retail management. This eclectic team offers over 500 cannabis products, including flowers, edibles, vapes, and accessories tailored to various dietary needs such as gluten-free and vegan options. The dispensary also plans to add delivery services soon. The opening of the Long Island Cannabis Club marks another milestone in the region's cannabis industry, which has seen slow but steady growth. Overcoming obstacles such as local regulations, permitting challenges, and landlord disputes, the dispensary reflects the determination of its owners to capitalize on the expanding cannabis market. Its launch aligns with other significant developments in the area, including the opening of additional dispensaries such as Strain Stars in Riverhead and Beleaf in Calverton. The cannabis industry on Long Island continues to evolve, with these new openings contributing to increased accessibility for consumers. The dispensaries aim to cater to a broad audience, from novice users to experienced enthusiasts, offering a wide range of high-quality, safe products. These efforts are part of a larger trend to normalize cannabis use and integrate it into local economies. As the industry grows, Long Island dispensaries are positioning themselves to become key players in a competitive market. Their focus on quality, innovation, and consumer education reflects the broader goals of the cannabis sector to meet both regulatory standards and community needs. https://lnkd.in/g3P9jPcn

2

1 Comment

The cannabis industry is evolving rapidly, driven by consumer demand for cannabinoids such as CBD and THC. However, this growth has highlighted the need for tighter regulations to ensure product safety, clear labeling, and responsible marketing. Enter the Cannabinoid Safety and Regulation Act (CSRA), a regulatory framework designed to bring order and transparency to the cannabis industry. #hemp #regulations #Cannabinoid #cannabis #laws #federallaw https://lnkd.in/gphu8-jC

31

2 Comments

Elevating New York Cannabis: A Clean Start with Gen Zero Tissue Culture Excited to see more microbusinesses taking root in NYS! With indoor flower on the horizon, there's incredible potential to revolutionize cannabis cultivation. Here's why starting with Gen Zero tissue culture clones might be your next big move: 🧬 Why Tissue Culture? Cannabis, as an annual plant, operates with a finite genetic lifespan. Cutting a clone from a mother plant does not reset its genetic clock; the clone carries the exact DNA of its source. Over time, the DNA in mother plants experiences breaks and deterioration, similar to how aging affects humans. This natural aging process, combined with environmental stressors, increases the risk of genetic drift (subtle but impactful changes in genetic expression) and mutations that can compromise the quality and consistency of your harvest. By starting with Gen Zero tissue culture clones, you bypass these risks entirely. Tissue culture provides a fresh start, delivering plants that are: - Pathogen-free: No lingering bacteria, fungi, or viruses. - Genetically true-to-type: Consistent characteristics from one plant to the next. - Vigorous and healthy: Free from the stress and wear accumulated in older plant generations. With tissue culture, you're ensuring that your cannabis plants grow with their genetic integrity intact, producing high-quality flower with every harvest. Don’t let aging genetics limit your operation—start clean and grow strong. 🌱 💰 Save Time, Space, and Money Operating a mother room is costly. Consider this: - Nutrients & Media: $500+/month - Power & Lighting: $1,000+/month - Water Usage: $300+/month - Labor Costs: $2,500+/month With Gen Zero clones, you can eliminate the mother room entirely, saving thousands annually while increasing operational efficiency. No mother plants mean reduced biosecurity risks since the perpetual operation of mother rooms makes them hotspots for pests and pathogens​​. 🌟 Your Path to Premium Flower Start clean and finish strong. Tissue-culture-derived clones from The New York Nursery guarantee uniform growth, consistent yields, and a superior end product. Whether you're growing for flavor, potency, or terpene content, our clones deliver​​. 🛠️ Let’s Grow Together Explore your options with us today and bring the best of science to your craft. We're here to help NY microbusinesses succeed! 📩 Reach out to The New York Nursery now. Start your journey with Gen Zero clones and cultivate with confidence. #NewYorkCannabis #TissueCulture #CannabisInnovation #CleanStart #GenZero #CannabisFarming #SustainableCannabis #CannabisCultivation #Microbusiness #GrowWithConfidence #CannabisScience #Biosecurity #PathogenFree #PremiumFlower #CannabisTech #NYSCannabis #FutureOfFarming #ConsistentQuality #CannabisMicrobusiness #StartCleanGrowStrong

17

1 Comment

🚨 Insightful DEA Report: Illicit marijuana flowers average a THC potency of 16%. 🌿💨 This statistic underscores a significant advantage of purchasing from licensed dispensaries—quality and safety. Unlike the unregulated market, dispensaries offer products that are tested, compliant, and consistent in their THC content. This not only ensures a safer consumer experience but also supports the legal cannabis industry committed to high standards. Why risk the unknown? Choose quality, safety, and reliability every time with dispensary-bought cannabis. Let's advocate for more informed consumer choices and support regulations that emphasize these benefits. Stay informed and choose wisely. #CannabisIndustry #ConsumerSafety #DispensaryQuality #THCPotency #RegulatedCannabis

18

6 Comments

CCB Meeting June 11, 2024 - 46.2 million in retail cannabis sales in ONE month New York’s cannabis industry is looking better than ever! Today’s CCB meeting featured a very positive market update showing the profitability of NY’s cannabis Industry. The month of May 2024 closed with an astonishing $46.2 million in retail cannabis sales, with weekly sales revenue reaching a record-high average of $12.5 million! This is a massive jump from the $6.7 million in retail sales made during the entire month of May 2023. With a grand total of $357.3 million in cannabis retail sales generated by 132 open and operating adult-use dispensaries, the New York market is poised for a future of continued growth. There’s no better time to start your New York cannabis business. Learn more about New York's cannabis market below! https://hubs.la/Q02Br-tY0 #NewYorkCannabis #NYC #CannabisBusiness #CannabisCulture

4

https://lnkd.in/eMBPBmBn I am really happy with the way these taste. Good creamy to crunchy ratio.

11

🚀 Highlights from the August 6, 2024, NYS Cannabis Control Board Meeting Here are the top takeaways from the latest meeting of the NYS Cannabis Control Board: 1. Retail Applicants Approved: -86 New Adult-Use Licenses: Including 22 retail dispensaries, 16 microbusinesses, 19 cultivators, 11 distributors, and 18 processors. -See the attached chart to review progress in the November Queue. 2. Changes to Allowances for Public Convenience: -The Board proposed new regulations for waiving the distance requirements between dispensaries in the name of public convenience. -The following will be considered: 1. The number, classes, and character of other licenses in proximity 2. If all necessary licenses and permits have been obtained  3. Whether there is a demonstrated need for such a license 4. The effect on pedestrian or vehicular traffic and parking 5. Noise levels 6. A history of cannabis violations and reported criminal activity  7. Any other factors specified by law or regulation 3. Clarification on Deficiency Responses: -It was mentioned that deficiencies must be responded to within 30 days, when previously it was emphasized that they needed to be resolved in that time. This distinction gives applicants more peace of mind when dealing with difficulties related to OCM technology. 4. Agenda Adjustments: -Aligned with decisions made in their previous meeting, the Board removed denials from the agenda at the last minute, focusing instead on moving forward with the application process and support for successful candidates. Licensing Update: -The state now boasts 156 licensed dispensaries with June retail sales reaching $71 million. Total sales since the program's launch are approaching half a billion dollars. -Nearly all conditional cultivators and processors have applied for full licenses, and the majority have been approved, with the expectation of closing out these applications in the next 2 meetings to focus on December supply side licenses. As the New York cannabis market continues to grow, these updates reflect our ongoing journey towards a regulated, equitable, and dynamic industry. Stay tuned for more developments! #CannabisIndustry #NYSCCB #CannabisRegulations #SocialEquity #CannabisLicensing #NewYorkCannabis

4

2 Comments

Significant support of the Council for Responsible Nutrition's litigation to overturn the New York law imposing age restrictions on dietary supplements. https://lnkd.in/e8B3accB The amicus brief outlines several arguments of the legal challenge, including: ☑ The statute uses labels and marketing, forms of protected speech, to determine its applicability, thereby burdening speech without adequate justification. ☑ The government’s defense and district court’s determination that the statute merely regulates conduct misreads that the key to whether a product is subject to the law depends on speech, and “reflects with distressing ease with which governments may seek to ‘control speech by recharacterizing it as conduct.’” ☑ The district court’s decision failed to recognize the statute’s implications for First Amendment rights, warranting a second review of the law and proper application of First Amendment scrutiny. ☑ The statute’s vague definitions and requirements place undue burdens on businesses, leading to potential punitive measures for inadvertent non-compliance. Read more in CRN's press release: https://lnkd.in/d4cKPD78

5

📢 Quick update from the latest NY Cannabis Control Board (CCB) meeting: Big milestones reached—over 1,100 adult-use licenses issued this year and the opening of New York's 200th dispensary! 🌱 The market is expanding fast. Currently, there are more licenses than active proximity protections, and we anticipate updates to some proximity protections by Oct 23rd. We’ll be looking into this and reporting back soon. Also, provisional licensees do not need to return to the board for final approval, meaning there may be fewer provisional licenses and more active retail operations than shown in the table. #NYCannabis #CannabisRegulations #MarketGrowth

17

Important Compliance Update: The Massachusetts Cannabis Control Commission has issued a bulletin on ground cannabis dust and workplace safety, following the death of a cannabis employee in 2022. Cannabis dust is now identified as a hazardous chemical, and licensees must inform employees about ground cannabis dust hazards. Read the bulletin here, and contact Stratacann today for assistance in updating your Standard Operating Procedures in applicable departments, no matter what market you operate in. #cannabissafety #cannabistraining #cannabisindustry

1

🚀 𝗢𝗽𝗽𝗼𝗿𝘁𝘂𝗻𝗶𝘁𝘆 𝗞𝗻𝗼𝗰𝗸𝘀 𝗶𝗻 𝗡𝗲𝘄 𝗝𝗲𝗿𝘀𝗲𝘆’𝘀 𝗘𝗺𝗲𝗿𝗴𝗶𝗻𝗴 𝗖𝗮𝗻𝗻𝗮𝗯𝗶𝘀 𝗠𝗮𝗿𝗸𝗲𝘁! 🚀 New Jersey is poised to become one of the most lucrative cannabis markets in the U.S. With very few operational cultivators and a population of over 2.6 million cannabis consumers, demand is rapidly outpacing supply. As neighboring states thrive, New Jersey residents are seeking high-quality products, leaving a major market opportunity untapped. At 𝗙𝗿𝗲𝘀𝗵 𝗖𝘂𝘁 𝗖𝗮𝗻𝗻𝗮𝗯𝗶𝘀, we see this as an incredible opportunity. Our bold product strategy is designed to deliver a premium cannabis experience to a discerning and educated consumer base. 𝗕𝘂𝘁 𝘄𝗵𝗮𝘁 𝘁𝗿𝘂𝗹𝘆 𝘀𝗲𝘁𝘀 𝘂𝘀 𝗮𝗽𝗮𝗿𝘁? 𝟭. 𝗦𝘁𝗿𝗮𝘁𝗲𝗴𝗶𝗰 𝗙𝗶𝗻𝗮𝗻𝗰𝗶𝗻𝗴: We've partnered with a leading New Jersey real estate developer for a build-to-suit facility, reducing capital requirements while securing next-generation infrastructure. 𝟮. 𝗠𝗮𝗿𝗸𝗲𝘁 𝗔𝗱𝘃𝗮𝗻𝘁𝗮𝗴𝗲: With limited operators, strict zoning laws, and challenging industrial real estate conditions, Fresh Cut’s early moves position us to build brand equity, crucial for long-term success. 𝟯. 𝗘𝘅𝗽𝗲𝗿𝗶𝗲𝗻𝗰𝗲𝗱 𝗟𝗲𝗮𝗱𝗲𝗿𝘀𝗵𝗶𝗽: Our team has deep industry expertise and a proven track record in navigating competitive cannabis markets. 📈 𝗖𝘂𝗿𝗿𝗲𝗻𝘁 𝗦𝘁𝗮𝘁𝘂𝘀 & 𝗜𝗻𝘃𝗲𝘀𝘁𝗺𝗲𝗻𝘁 𝗛𝗶𝗴𝗵𝗹𝗶𝗴𝗵𝘁𝘀: • Fresh Cut is a fully licensed cultivator and manufacturer in New Jersey. • Finalizing all local permits to achieve a shovel-ready property. • Successfully raised $1.2 million to date and are currently seeking $265k to close our seed round. • Strong early interest in our $5 million Series A, which will fully operationalize our facility and bring the company to cash flow positivity. This is your chance to be part of something special. Fresh Cut is paving the way to become a driving force in the New Jersey cannabis scene, and we’re seeking investors who share our vision for growth. 🌿 Join us in revolutionizing cannabis in the Garden State! 🌿 𝗙𝗖 𝗦𝗲𝗿𝗶𝗲𝘀 𝗔 𝗜𝗻𝘃𝗲𝘀𝘁𝗼𝗿 𝗗𝗲𝗰𝗸  https://lnkd.in/ezchCXz4 Matthew Budofsky Michael Law Fresh Cut Cannabis Co. #CannabisIndustry #NewJerseyCannabis #InvestmentOpportunity #FreshCutCannabis #CannabisEntrepreneurship #CannabisInvesting #SeriesAInvesting

15

Navigating #Amazon's New #DietarySupplements #Policy can be daunting, but Nuherbs' own Lisa Thomas is here to simplify it for us. In her insightful article, Lisa unpacks the recent updates from Amazon that affect anyone in our industry selling dietary supplements. These changes are crucial for ensuring our products are not only compliant with FDA regulations but also meeting Amazon’s stringent new requirements. From increased scrutiny to mandatory third-party testing, the landscape is shifting. Why is this important? Because these changes underscore a collective effort toward greater transparency, safety, and quality—values that resonate deeply with us at Nuherbs and our commitment to you. https://lnkd.in/gxFWRYsS Let's stay informed and proactive together. If you have questions, reach out to us, and let's ensure your operations align seamlessly with these new standards.

31

1 Comment

“Prescription Cannabis - Smoking vs Vaping” • The landscape of prescription cannabis consumption has evolved, offering users diverse methods to embrace the plant’s benefits based on individual preference and desired effects • Two prevalent methods today are vaping and smoking • Smoking- Cannabis smoking, a traditional consumption method, involves inhaling the smoke from combusting dried cannabis flower • Vaping - Cannabis vaping has become a modern, popular method, offering a controlled and nuanced experience. Unlike smoking, vaping doesn’t involve combustion; specialized devices heat cannabis concentrates or flower to release cannabinoids and terpenes as vapor • Safety- Regardless of smoking or vaping, understanding health impacts is crucial • As cannabis ages, its chemical composition changes. Improper storage conditions can degrade cannabinoids and terpenes, impacting efficacy. Mold or mildew growth becomes a concern, posing health risks. Store cannabis in a cool, dark, airtight environment, regularly checking for signs of aging or contamination https://lnkd.in/ePdwVrGZ

16

3 Comments